Drug Profile
G protein-coupled receptor modulator - Taisho Pharmaceutical
Latest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Arena Pharmaceuticals; Taisho Pharmaceutical
- Developer Taisho Pharmaceutical
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Psychiatric disorders
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 01 Jan 2013 Discontinued - Phase-I for Psychiatric disorders in Japan (PO)
- 07 May 2008 Phase-I clinical trials in Psychiatric disorders in Japan (PO)